Kyle Piskel, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 18,672 shares at $13.17 ($246K) on 2026-03-11, disclosed to the SEC on 2026-03-13.
Seasonal sale ($246k) by Chief Financial Officer — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ADPT | SELL | 2026-01-14 | $77K | — | Filing → |
| ADPT | SELL | 2025-12-02 | $3.2M | — | Filing → |
| ADPT | SELL | 2025-11-18 | $3K | — | Filing → |